Global Latent TB Infection Testing Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Latent TB Infection Testing Market Size 2017-2028

2.1.2 Latent TB Infection Testing Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Latent TB Infection Testing Segment by Type

2.2.1 Mantoux Test / Tuberculin Skin Test (TST)

2.2.2 Interferon-Gamma Release Assay (IGRA)

2.3 Latent TB Infection Testing Market Size by Type

2.3.1 Latent TB Infection Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Latent TB Infection Testing Market Size Market Share by Type (2017-2022)

2.4 Latent TB Infection Testing Segment by Application

2.4.1 Hospitals

2.4.2 Public and Student Health

2.4.3 Physician Offices and Clinics

2.4.4 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)

2.5 Latent TB Infection Testing Market Size by Application

2.5.1 Latent TB Infection Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Latent TB Infection Testing Market Size Market Share by Application (2017-2022)

3 Latent TB Infection Testing Market Size by Player

3.1 Latent TB Infection Testing Market Size Market Share by Players

3.1.1 Global Latent TB Infection Testing Revenue by Players (2020-2022)

3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2020-2022)

3.2 Global Latent TB Infection Testing Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Latent TB Infection Testing by Regions

4.1 Latent TB Infection Testing Market Size by Regions (2017-2022)

4.2 Americas Latent TB Infection Testing Market Size Growth (2017-2022)

4.3 APAC Latent TB Infection Testing Market Size Growth (2017-2022)

4.4 Europe Latent TB Infection Testing Market Size Growth (2017-2022)

4.5 Middle East & Africa Latent TB Infection Testing Market Size Growth (2017-2022)

5 Americas

5.1 Americas Latent TB Infection Testing Market Size by Country (2017-2022)

5.2 Americas Latent TB Infection Testing Market Size by Type (2017-2022)

5.3 Americas Latent TB Infection Testing Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Latent TB Infection Testing Market Size by Region (2017-2022)

6.2 APAC Latent TB Infection Testing Market Size by Type (2017-2022)

6.3 APAC Latent TB Infection Testing Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Latent TB Infection Testing by Country (2017-2022)

7.2 Europe Latent TB Infection Testing Market Size by Type (2017-2022)

7.3 Europe Latent TB Infection Testing Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Latent TB Infection Testing by Region (2017-2022)

8.2 Middle East & Africa Latent TB Infection Testing Market Size by Type (2017-2022)

8.3 Middle East & Africa Latent TB Infection Testing Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Latent TB Infection Testing Market Forecast

10.1 Global Latent TB Infection Testing Forecast by Regions (2023-2028)

10.1.1 Global Latent TB Infection Testing Forecast by Regions (2023-2028)

10.1.2 Americas Latent TB Infection Testing Forecast

10.1.3 APAC Latent TB Infection Testing Forecast

10.1.4 Europe Latent TB Infection Testing Forecast

10.1.5 Middle East & Africa Latent TB Infection Testing Forecast

10.2 Americas Latent TB Infection Testing Forecast by Country (2023-2028)

10.2.1 United States Latent TB Infection Testing Market Forecast

10.2.2 Canada Latent TB Infection Testing Market Forecast

10.2.3 Mexico Latent TB Infection Testing Market Forecast

10.2.4 Brazil Latent TB Infection Testing Market Forecast

10.3 APAC Latent TB Infection Testing Forecast by Region (2023-2028)

10.3.1 China Latent TB Infection Testing Market Forecast

10.3.2 Japan Latent TB Infection Testing Market Forecast

10.3.3 Korea Latent TB Infection Testing Market Forecast

10.3.4 Southeast Asia Latent TB Infection Testing Market Forecast

10.3.5 India Latent TB Infection Testing Market Forecast

10.3.6 Australia Latent TB Infection Testing Market Forecast

10.4 Europe Latent TB Infection Testing Forecast by Country (2023-2028)

10.4.1 Germany Latent TB Infection Testing Market Forecast

10.4.2 France Latent TB Infection Testing Market Forecast

10.4.3 UK Latent TB Infection Testing Market Forecast

10.4.4 Italy Latent TB Infection Testing Market Forecast

10.4.5 Russia Latent TB Infection Testing Market Forecast

10.5 Middle East & Africa Latent TB Infection Testing Forecast by Region (2023-2028)

10.5.1 Egypt Latent TB Infection Testing Market Forecast

10.5.2 South Africa Latent TB Infection Testing Market Forecast

10.5.3 Israel Latent TB Infection Testing Market Forecast

10.5.4 Turkey Latent TB Infection Testing Market Forecast

10.5.5 GCC Countries Latent TB Infection Testing Market Forecast

10.6 Global Latent TB Infection Testing Forecast by Type (2023-2028)

10.7 Global Latent TB Infection Testing Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)

11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Information

11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered

11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business Overview

11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments

11.2 Pharmstandard (Generium Pharmaceutical)

11.2.1 Pharmstandard (Generium Pharmaceutical) Company Information

11.2.2 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered

11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pharmstandard (Generium Pharmaceutical) Main Business Overview

11.2.5 Pharmstandard (Generium Pharmaceutical) Latest Developments

11.3 Sanofi S.A./Sanofi Pasteur Ltd.

11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Information

11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered

11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Main Business Overview

11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments

11.4 Statens Serum Institut (SSI)

11.4.1 Statens Serum Institut (SSI) Company Information

11.4.2 Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered

11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Statens Serum Institut (SSI) Main Business Overview

11.4.5 Statens Serum Institut (SSI) Latest Developments

11.5 Autoimmun Diagnostika (AID) GmbH

11.5.1 Autoimmun Diagnostika (AID) GmbH Company Information

11.5.2 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered

11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Autoimmun Diagnostika (AID) GmbH Main Business Overview

11.5.5 Autoimmun Diagnostika (AID) GmbH Latest Developments

11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Information

11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered

11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business Overview

11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments

11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)

11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Information

11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered

11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business Overview

11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments

11.8 Immunoshop India Pvt. Ltd.

11.8.1 Immunoshop India Pvt. Ltd. Company Information

11.8.2 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered

11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Immunoshop India Pvt. Ltd. Main Business Overview

11.8.5 Immunoshop India Pvt. Ltd. Latest Developments

11.9 Qiagen N.V.

11.9.1 Qiagen N.V. Company Information

11.9.2 Qiagen N.V. Latent TB Infection Testing Product Offered

11.9.3 Qiagen N.V. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Qiagen N.V. Main Business Overview

11.9.5 Qiagen N.V. Latest Developments

11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)

11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Information

11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered

11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business Overview

11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments

11.11 SD Biosensor, Inc.

11.11.1 SD Biosensor, Inc. Company Information

11.11.2 SD Biosensor, Inc. Latent TB Infection Testing Product Offered

11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 SD Biosensor, Inc. Main Business Overview

11.11.5 SD Biosensor, Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Latent TB Infection Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Mantoux Test / Tuberculin Skin Test (TST)

Table 3. Major Players of Interferon-Gamma Release Assay (IGRA)

Table 4. Latent TB Infection Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Latent TB Infection Testing Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Latent TB Infection Testing Market Size Market Share by Type (2017-2022)

Table 7. Latent TB Infection Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Latent TB Infection Testing Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Latent TB Infection Testing Market Size Market Share by Application (2017-2022)

Table 10. Global Latent TB Infection Testing Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Latent TB Infection Testing Revenue Market Share by Player (2020-2022)

Table 12. Latent TB Infection Testing Key Players Head office and Products Offered

Table 13. Latent TB Infection Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Latent TB Infection Testing Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Latent TB Infection Testing Market Size Market Share by Regions (2017-2022)

Table 18. Americas Latent TB Infection Testing Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Latent TB Infection Testing Market Size Market Share by Country (2017-2022)

Table 20. Americas Latent TB Infection Testing Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Latent TB Infection Testing Market Size Market Share by Type (2017-2022)

Table 22. Americas Latent TB Infection Testing Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Latent TB Infection Testing Market Size Market Share by Application (2017-2022)

Table 24. APAC Latent TB Infection Testing Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Latent TB Infection Testing Market Size Market Share by Region (2017-2022)

Table 26. APAC Latent TB Infection Testing Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Latent TB Infection Testing Market Size Market Share by Type (2017-2022)

Table 28. APAC Latent TB Infection Testing Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Latent TB Infection Testing Market Size Market Share by Application (2017-2022)

Table 30. Europe Latent TB Infection Testing Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Latent TB Infection Testing Market Size Market Share by Country (2017-2022)

Table 32. Europe Latent TB Infection Testing Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Latent TB Infection Testing Market Size Market Share by Type (2017-2022)

Table 34. Europe Latent TB Infection Testing Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Latent TB Infection Testing Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Latent TB Infection Testing Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Latent TB Infection Testing Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Latent TB Infection Testing Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Latent TB Infection Testing

Table 43. Key Market Challenges & Risks of Latent TB Infection Testing

Table 44. Key Industry Trends of Latent TB Infection Testing

Table 45. Global Latent TB Infection Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Latent TB Infection Testing Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Latent TB Infection Testing Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Latent TB Infection Testing Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Latent TB Infection Testing Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Latent TB Infection Testing Market Size Market Share Forecast by Application (2023-2028)

Table 51. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 52. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered

Table 53. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business

Table 55. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments

Table 56. Pharmstandard (Generium Pharmaceutical) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 57. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered

Table 58. Pharmstandard (Generium Pharmaceutical) Main Business

Table 59. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Pharmstandard (Generium Pharmaceutical) Latest Developments

Table 61. Sanofi S.A./Sanofi Pasteur Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 62. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered

Table 63. Sanofi S.A./Sanofi Pasteur Ltd. Main Business

Table 64. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments

Table 66. Statens Serum Institut (SSI) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 67. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered

Table 68. Statens Serum Institut (SSI) Main Business

Table 69. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Statens Serum Institut (SSI) Latest Developments

Table 71. Autoimmun Diagnostika (AID) GmbH Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 72. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered

Table 73. Autoimmun Diagnostika (AID) GmbH Main Business

Table 74. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Autoimmun Diagnostika (AID) GmbH Latest Developments

Table 76. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 77. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered

Table 78. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business

Table 79. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments

Table 81. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 82. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered

Table 83. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business

Table 84. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments

Table 86. Immunoshop India Pvt. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 87. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered

Table 88. Immunoshop India Pvt. Ltd. Main Business

Table 89. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Immunoshop India Pvt. Ltd. Latest Developments

Table 91. Qiagen N.V. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 92. Qiagen N.V. Latent TB Infection Testing Product Offered

Table 93. Qiagen N.V. Main Business

Table 94. Qiagen N.V. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Qiagen N.V. Latest Developments

Table 96. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 97. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered

Table 98. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business

Table 99. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments

Table 101. SD Biosensor, Inc. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors

Table 102. SD Biosensor, Inc. Latent TB Infection Testing Product Offered

Table 103. SD Biosensor, Inc. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. SD Biosensor, Inc. Main Business

Table 105. SD Biosensor, Inc. Latest Developments

List of Figures

Figure 1. Latent TB Infection Testing Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Latent TB Infection Testing Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Latent TB Infection Testing Market Size Market Share by Type in 2021

Figure 7. Latent TB Infection Testing in Hospitals

Figure 8. Global Latent TB Infection Testing Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Latent TB Infection Testing in Public and Student Health

Figure 10. Global Latent TB Infection Testing Market: Public and Student Health (2017-2022) & ($ Millions)

Figure 11. Latent TB Infection Testing in Physician Offices and Clinics

Figure 12. Global Latent TB Infection Testing Market: Physician Offices and Clinics (2017-2022) & ($ Millions)

Figure 13. Latent TB Infection Testing in Others (Military, Correctional Facilities, Chronic Care Homes, and Others)

Figure 14. Global Latent TB Infection Testing Market: Others (Military, Correctional Facilities, Chronic Care Homes, and Others) (2017-2022) & ($ Millions)

Figure 15. Global Latent TB Infection Testing Market Size Market Share by Application in 2021

Figure 16. Global Latent TB Infection Testing Revenue Market Share by Player in 2021

Figure 17. Global Latent TB Infection Testing Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Latent TB Infection Testing Market Size 2017-2022 ($ Millions)

Figure 19. APAC Latent TB Infection Testing Market Size 2017-2022 ($ Millions)

Figure 20. Europe Latent TB Infection Testing Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Latent TB Infection Testing Market Size 2017-2022 ($ Millions)

Figure 22. Americas Latent TB Infection Testing Value Market Share by Country in 2021

Figure 23. Americas Latent TB Infection Testing Consumption Market Share by Type in 2021

Figure 24. Americas Latent TB Infection Testing Market Size Market Share by Application in 2021

Figure 25. United States Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Latent TB Infection Testing Market Size Market Share by Region in 2021

Figure 30. APAC Latent TB Infection Testing Market Size Market Share by Application in 2021

Figure 31. China Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Latent TB Infection Testing Market Size Market Share by Country in 2021

Figure 38. Europe Latent TB Infection Testing Market Size Market Share by Type in 2021

Figure 39. Europe Latent TB Infection Testing Market Size Market Share by Application in 2021

Figure 40. Germany Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application in 2021

Figure 48. Egypt Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Latent TB Infection Testing Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 54. APAC Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 55. Europe Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 57. United States Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 58. Canada Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 61. China Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 62. Japan Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 63. Korea Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 65. India Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 66. Australia Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 67. Germany Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 68. France Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 69. UK Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 70. Italy Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 71. Russia Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 72. Spain Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 75. Israel Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Latent TB Infection Testing Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Latent TB Infection Testing Market Size 2023-2028 ($ Millions)